At close: 4:00:02 PM EST
After hours: 4:01:28 PM EST
Research Analysis
Earnings Estimate
| Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | -- | 3 | 3 |
| Avg. Estimate | -0.19 | 0 | -0.54 | -0.08 |
| Low Estimate | -0.2 | 0 | -0.55 | -0.75 |
| High Estimate | -0.17 | 0 | -0.52 | 0.36 |
| Year Ago EPS | -0.05 | -0.18 | -0.64 | -0.54 |
Revenue Estimate
| Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 1 | 4 | 4 |
| Avg. Estimate | 742.32k | -- | 26.97M | 56.96M |
| Low Estimate | -- | -- | 26.17M | -- |
| High Estimate | 1.3M | -- | 27.5M | 132.04M |
| Year Ago Sales | 14.8M | -- | 14.8M | 26.97M |
| Sales Growth (year/est) | -94.98% | 0.00% | 82.21% | 111.20% |
Earnings History
| Currency in CHF | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.16 | -0.12 | 0.25 | -0.19 |
| EPS Actual | -0.05 | -0.18 | -0.23 | 0.05 |
| Difference | 0.11 | -0.06 | -0.48 | 0.24 |
| Surprise % | 68.35% | -53.19% | -193.50% | 125.86% |
EPS Trend
| Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.19 | 0 | -0.54 | -0.08 |
| 7 Days Ago | -0.19 | 0 | -0.54 | -0.03 |
| 30 Days Ago | -0.19 | 0 | -0.54 | -0.03 |
| 60 Days Ago | -0.19 | 0 | -0.54 | -0.03 |
| 90 Days Ago | -0.18 | 0 | -0.78 | 0.01 |
EPS Revisions
| Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ACIU | -280.66% | -- | 15.52% | 85.76% |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/15/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/18/2024 |
| Initiated | BTIG: Buy | 5/31/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/15/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2023 |
Related Tickers
OBIO Orchestra BioMed Holdings, Inc.
5.47
+1.86%
MGTX MeiraGTx Holdings plc
6.20
-2.36%
IMRX Immuneering Corporation
2.0700
+3.50%
SPRC SciSparc Ltd.
0.8149
+1.03%
MURA Mural Oncology plc
3.8900
+6.58%
SCPX Scorpius Holdings, Inc.
0.3800
-0.26%
MBIO Mustang Bio, Inc.
0.2566
+15.38%
BLRX BioLineRx Ltd.
0.1429
+0.21%
CTMX CytomX Therapeutics, Inc.
0.8801
-10.45%
CERO CERo Therapeutics Holdings, Inc.
2.9600
-20.00%